Golden, Thanks @dachopper
I just wanted that to be crystal clear for everyone we are talking “annual” 2 Billion in sales for MSB’s first Ryoncil(Rem-L) therapy for Paeds and Adult aGVHD.
And this will be MSB’s smallest therapy use in the larger MSB plan. Full LBP and HF will be many many multiples of this revenue figure if/when Rex is approved.
As I said….Golden.
Golden, Thanks @dachopperI just wanted that to be crystal clear...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.030(2.73%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.21 | $1.05 | $28.73M | 25.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14264 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 24626 | 3 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
-0.030 ( 2.52 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.21 | $1.05 | 5190842 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| MSB (ASX) Chart |